A Precision Medicine Approach to Improve Cancer Rehabilitation’s Impact and Integration with Cancer Care and Optimize Patient Wellness
- 204 Downloads
Purpose of Review
Many patients treated for cancer develop toxicities that go unaddressed, limiting their functioning, health, quality of life, and ability to work. This review describes how to optimize patient functioning and quality of life by preventing toxicities where possible or treating them early to reduce impairment and prevent disability.
Increasing the impact of cancer rehabilitation on preventing and treating toxicity requires filling research gaps and better integrating rehabilitation with cancer care.
We must understand risk factors and the underlying biology driving impairments, disability, and individual response to intervention. Then, we need to integrate these data and implement screening of all patients throughout treatment and beyond to (1) monitor biological changes that would lead to downstream impairments and facilitate referrals for personalized rehabilitation interventions to prevent these; (2) where prevention is impossible, screen for impairments and prescribe interventions to treat them early; or (3) intervene to prevent disability resulting from impairments that cannot be prevented or treated.
KeywordsCancer Oncology Survivorship Toxicity Precision medicine Rehabilitation Cancer rehabilitation
Compliance with Ethical Standards
Conflict of Interest
Lee W. Jones reports grants from the National Cancer Institute, the Memorial Sloan Kettering Cancer Center Support Grant/Core Grant (P30 CA008748), and ATKIV Against Cancer.
Nathan D. Price is cofounder of and holds stock with Arivale, reports grants from Jassen Pharmaceuticals, reports grants from Amgen, reports grants from GBM, and reports grants from and serves as board member for Habit.
Kathryn H. Schmitz is supported by research grants from the National Cancer Institute and the Chinchilli Family Foundation.
Catherine M. Alfano, David S. Zucker, Mackenzi Pergolotti, Kirsten K. Ness, and Jennifer A. Ligibel declare that they have no conflict of interest.
Human and Animal Rights and Informed Consent
This article does not contain any studies with human or animal subjects performed by any of the authors.
Papers of particular interest, published recently, have been highlighted as: • Of important •• Of major importance
- 1.• American Cancer Society. Cancer facts & figures 2016. Atlanta: American Cancer Society; 2016. An estimated 1,685,210 new cancer cases are expected to be diagnosed in the USA in 2016.Google Scholar
- 2.Stubblefield MD, O’Dell MW, editors. Cancer rehabilitation principles and practice. New York: Demos Medical Publishing; 2009.Google Scholar
- 6.Hewitt M, Greenfield S, Stovall E, editors. From cancer patient to cancer survivor: lost in transition. Washington DC: National Academies Press; 2006.Google Scholar
- 7.Hewitt M, Weiner SL, Simone JV, editors. Childhood cancer survivorship: improving care and quality of Life. Washington, DC: The National Academies Press; 2003.Google Scholar
- 12.Adler NE, Page A. National Institue of Medicine (U. S.) Committee on Psychosocial Services to Cancer Patients/Families in a Community Setting. Cancer care for the whole patient: meeting psychosocial health needs. Washington, D.C.: National Academies Press; 2008. xxii, 429 p.Google Scholar
- 20.•• Brown JC, Harhay MO, Harhay MN. Patient-reported versus objectively-measured physical function and mortality risk among cancer survivors. J Geriatr Oncol. 2016;7(2):108–15. Sixty-six percent of cancer survivors reported at least one physical limitation. Each additional functional limitation was associated with 19% increased risk of death CrossRefPubMedPubMedCentralGoogle Scholar
- 22.• American Cancer Society. Cancer treatment and survivorship facts & figures 2016–2017. Atlanta, GA: American Cancer Society; 2016. An estimated 15.5 million cancer survivors were alive in the USA as of January 1, 2016. The population of cancer survivors is expected to reach 20.3 million by January 1, 2026.Google Scholar
- 23.• National Cancer Institute. Cancer Moonshot Blue Ribbon Panel Report. [Available from: https://www.cancer.gov/research/key-initiatives/moonshot-cancer-initiative/blue-ribbon-panel/blue-ribbon-panel-report-2016.pdf. 2016. Minimizing cancer treatment’s debilitating side effects is listed as one of the key areas where the NCI Blue Ribbon Panel recommends that we make 10 years of progress in 5 years.
- 25.Duijts SF, Faber MM, Oldenburg HS, van Beurden M, Aaronson NK. Effectiveness of behavioral techniques and physical exercise on psychosocial functioning and health-related quality of life in breast cancer patients and survivors—a meta-analysis. Psychooncology. 2011;20(2):115–26.CrossRefPubMedGoogle Scholar
- 26.Fode M, Serefoglu EC, Albersen M, Sonksen J. Sexuality following radical prostatectomy: is restoration of erectile function enough? Sex Med Rev. 2016.Google Scholar
- 27.Mishra SI, Scherer RW, Snyder C, Geigle PM, Berlanstein DR, Topaloglu O. Exercise interventions on health-related quality of life for people with cancer during active treatment. Cochrane Database Syst Rev. 2012;8:CD008465.Google Scholar
- 30.Lehmann JF, DeLisa JA, Warren CG, deLateur BJ, Bryant PL, Nicholson CG. Cancer rehabilitation: assessment of need, development, and evaluation of a model of care. Arch Phys Med Rehabil 1978;59(9):410–419.Google Scholar
- 33.Stout NL, Silver JK, Raj VS, Rowland J, Gerber L, Cheville A, et al. Toward a national initiative in cancer rehabilitation: recommendations from a subject matter expert group. Arch Phys Med Rehabil. 2016.Google Scholar
- 38.Fu MR, Conley YP, Axelrod D, Guth AA, Yu G, Fletcher J, et al. Precision assessment of heterogeneity of lymphedema phenotype, genotypes and risk prediction. Breast. 2016.Google Scholar
- 53.Guenancia C, Lefebvre A, Cardinale D, Yu AF, Ladoire S, Ghiringhelli F, et al.. Obesity as a risk factor for anthracyclines and trastuzumab cardiotoxicity in breast cancer: a systematic review and meta-analysis. J Clin Oncol. 2016.Google Scholar
- 63.Paxton RJ, Phillips KL, Jones LA, Chang S, Taylor WC, Courneya KS, et al. Associations among physical activity, body mass index, and health-related quality of life by race/ethnicity in a diverse sample of breast cancer survivors. Cancer. 2012;118(16):4024–31.CrossRefPubMedPubMedCentralGoogle Scholar
- 74.• Mohile SG, Velarde C, Hurria A, Magnuson A, Lowenstein L, Pandya C, et al. Geriatric assessment-guided care processes for older adults: a Delphi consensus of geriatric oncology experts. J National Compr Cancer Netw. 2015;13(9):1120–30. This article describes the results of a Delphi study of content experts who agree that a comprehensive geriatric assessment should be used to determine cancer treatment plans to decrease the risk for chemotherapy toxicity.Google Scholar
- 75.Extermann M, Aapro M, Bernabei R, Cohen HJ, Droz J-P, Lichtman S, et al. Use of comprehensive geriatric assessment in older cancer patients: recommendations from the task force on CGA of the International Society of Geriatric Oncology (SIOG). Crit Rev Oncol Hematol. 2005;55(3):241–52.CrossRefPubMedGoogle Scholar
- 76.Hurria A, Akiba C, Kim J, Mitani D, Loscalzo M, Katheria V, et al. Reliability, validity, and feasibility of a computer-based geriatric assessment for older adults with cancer. J Oncol Pract. 2016.Google Scholar
- 82.• Ness KK, Krull KR, Jones KE, Mulrooney DA, Armstrong GT, Green DM, et al. Physiologic frailty as a sign of accelerated aging among adult survivors of childhood cancer: a report from the St Jude Lifetime cohort study. J Clin Oncol. 2013;31(36):4496–503. Compared to siblings, survivors of childhood cancer were more likely to report poor general health, mental health, functional impairment, and activity limitations.CrossRefPubMedPubMedCentralGoogle Scholar
- 85.Braam KI, van der Torre P, Takken T, Veening MA, van Dulmen-den Broeder E, Kaspers GJ. Physical exercise training interventions for children and young adults during and after treatment for childhood cancer. Cochrane Database Syst Rev. 2013;4:CD008796.Google Scholar
- 86.Henderson TO, Ness KK, Cohen HJ. Accelerated aging among cancer survivors: from pediatrics to geriatrics. Am Soc Clin Oncol Educ Book. 2014:e423–30.Google Scholar
- 99.Huang C, Zhang X, Ramil JM, Rikka S, Kim L, Lee Y, et al. Juvenile exposure to anthracyclines impairs cardiac progenitor cell function and vascularization resulting in greater susceptibility to stress-induced myocardial injury in adult mice. Circulation. 2010;121(5):675–83.CrossRefPubMedPubMedCentralGoogle Scholar
- 102.• Basch E, Wood WA, Schrag D, Sima CS, Shaw M, Rogak LJ, et al. Feasibility and clinical impact of sharing patient-reported symptom toxicities and performance status with clinical investigators during a phase 2 cancer treatment trial. Clinical Trials. 2015. Use of tablet computers to report patient symptoms to oncology providers helped clinicians more accurately estimate patient symptoms and led to clinical actions for symptom management. Google Scholar
- 104.Wildes TM, Depp B, Colditz G, Stark S. Fall-risk prediction in older adults with cancer: an unmet need. Support Care Cancer Off J Multinat Assoc Support Care Cancer. 2016;24(9):3681–4.Google Scholar
- 111.Fernandez-Pineda I, Hudson MM, Pappo AS, Bishop MW, Klosky JL, Brinkman TM, et al. Long-term functional outcomes and quality of life in adult survivors of childhood extremity sarcomas: a report from the St. Jude Lifetime Cohort Study. J Cancer Surviv. 2016.Google Scholar
- 112.Marina N, Hudson MM, Jones KE, Mulrooney DA, Avedian R, Donaldson SS, et al. Changes in health status among aging survivors of pediatric upper and lower extremity sarcoma: a report from the childhood cancer survivor study. Arch Phys Med Rehabil. 2013;94(6):1062–73.CrossRefPubMedPubMedCentralGoogle Scholar